Abstract
This study evaluated the impact of province-wide treatment guidelines on consistency of adjuvant therapy for node-negative breast cancer. A retrospective population-based cohort study was conducted in the Canadian provinces of British Columbia, which has province-wide guidelines, and Ontario, which does not. All eligible 1991 incident cases of node-negative breast cancer in British Columbia (n = 942) and a similar number of randomly selected 1991 incident cases in Ontario (n = 938) were reviewed. Consistency of adjuvant therapy received was evaluated by stratifying cases into discrete diagnostic groups using several grouping systems, and by then comparing the distribution of treatments received within each diagnostic group in the two provinces. Recursive partitioning was also performed. We observed that patterns of pathology reporting were consistent with awareness of the factors used in the British Columbia guidelines to define indications for adjuvant therapy. Consistency of care was greater in British Columbia than in Ontario by all diagnostic grouping systems and by recursive partitioning (P < 0.001), and the observed patterns in British Columbia corresponded to the British Columbia guidelines. We conclude that population-based treatment guidelines can play a role in promoting consistent patterns of adjuvant therapy for women with node-negative breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Sawka, C., Olivotto, I., Coldman, A. et al. The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer. Br J Cancer 75, 1534–1542 (1997). https://doi.org/10.1038/bjc.1997.262
Issue Date:
DOI: https://doi.org/10.1038/bjc.1997.262
This article is cited by
-
Effect of Community Population Size on Breast Cancer Screening, Stage Distribution, Treatment Use and Outcomes
Canadian Journal of Public Health (2012)
-
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group
Medical Oncology (2012)
-
A population-based study of gefitinib in patients with non-small cell lung cancer
Medical Oncology (2009)
-
Cancer Survival in Ontario, 1986–2003
Canadian Journal of Public Health (2008)
-
Evaluating the organization and delivery of breast cancer services: use of performance measures to identify knowledge gaps
Breast Cancer Research and Treatment (2007)